EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
HealthEquity, Inc.
HQY

HQY HealthEquity, Inc.

HealthEquity, Inc. · NASDAQ
Market Closed
96.26
▲ ⁦+1.81%⁩ (+1.71)
Market Cap$8.0B
Beta0.21
52w Low52w High
72.76107.62
Last Week
⁦-0.76%⁩
Last Month
⁦-6.94%⁩
Last 3 Months
⁦+9.40%⁩
Last Year
⁦+9.41%⁩
EL7 Factor Analysis
How we score this
Overall94
Excellent — top fifth of the marketHigh FlyerF 9/9SafeBetter than 94% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
37
34.6x▼17.8xBottom tier
▸
Growth
78
7.3%▲7.1%Top tier
▸
Quality
86
9.1%▲4.5%Top tier
▸
Safety
78
1.4x▲2.6xTop tier
▸
Capital Return
79
—2.12%Top tier
▸
Momentum
73
16.9%▲2.9%Top tier
▸
Sentiment
74
11▲3Top tier
Fair Value
Current price$96
Analyst target · 4 analysts
$111
⁦+15%⁩
See it undervalued
Range ⁦$105–$142⁩
vs
DCF (estimate)
$103
⁦+7%⁩
Sees it undervalued
⁦7.9⁩% discount · ⁦3⁩% growth
Bottom lineThe two methods broadly agree — estimate range ⁦$103–$111⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 4 analysts setting price target
$115.33
⁦+19.8%⁩
Current Price $96.26·Median $111.00
Low
$105.00
High
$142.00
Current price
$96.26
Average target
$115.33
Street summary

Higher Target-Price Consensus While Ratings Remain Stable

Bullish tilt

HealthEquity’s target-price consensus rose to 115.33 from 108.38 over the last 30 days, an increase of 6.95 or 6.41%, while the number of analysts remained unchanged at four. No changes were recorded over the last day or seven days, indicating recent stability following the previous increase. The current range is between 105 and 142, with a median of 111 versus a current price of 96.07, reflecting a clear divergence among estimates despite the consensus leaning optimistic.

As of 2026-09-07
Revisions momentum · 30d
⁦+6.4%⁩
Average rating
★ 4.33
Buy
Analyst coverage
15
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
38%
Wide
Analyst ratings over time15 analysts rating
5
10
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.12 → 4.33
Recent analyst moves
  • = Reiterate2026-09-03
    Raymond James
    Strong Buy
  • = Reiterate2026-08-31
    Deutsche Bank
    Buy
  • = Reiterate2026-08-28
    Citigroup
    Market Outperform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    34.63x
    3.94x44.30x
    Near median
  • Forward P/E
    18.63x
    4.64x37.16x
    Cheap
  • EV / EBITDA
    17.05x
    3.77x30.13x
    Cheap
  • FCF Yield
    6.1%
    -138.2%7.8%
    Strong
  • Revenue Growth YoY
    7.3%
    -56.9%93.8%
    Near median
  • EPS Growth YoY
    68.5%
    -160.1%130.2%
    Strong
  • Gross Margin
    71.2%
    12.8%90.7%
    Strong
  • ROIC
    9.1%
    -155.3%16.0%
    Strong
  • Net Debt / EBITDA
    1.40x
    0.60x5.10x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    4.68
    -38.7417.53
    Strong
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-27 data

Company Overview

HealthEquity operates a healthcare financial platform that connects health savings accounts HSA, assets, payments, investing, advisory services, and Marketplace in an integrated experience. The company generates revenue from three main streams: service fees associated with accounts and platform usage, custodial revenue generated from HSA cash balances, and interchange fees associated with member spending and cards. In Q2 fiscal 2027, service revenue was $124.4 million, custodial revenue was $175.9 million, and interchange revenue was $50.4 million, showing that custodial revenue was the largest component of the quarter's $350.7 million in revenue.

In Q2 fiscal 2027, revenue grew 8% year over year to $350.7 million, and gross profit reached a record $258.0 million, equivalent to a gross margin of approximately 74% versus 71% in the comparable period. GAAP net income was $65.6 million, or $0.78 per diluted share, while non-GAAP net income was $103.8 million, or $1.24 per diluted share. Adjusted earnings before interest, taxes, depreciation, and amortization also increased 11% to $167 million, and its margin reached a record 48% versus 46% in Q2 fiscal 2026.

During the first half of fiscal 2027, HealthEquity generated revenue of $705.4 million, up 7%, net income of $135.1 million, and adjusted earnings before interest, taxes, depreciation, and amortization of $331.5 million, up 14% with a 47% margin. These results are supported by a base of 10.7 million HSA accounts, while total HSA accounts grew 8% and total HSA assets grew 14% in Q2 fiscal 2027. According to EDGAR data for the twelve-month period ending in fiscal 2027, revenue was $1.4 billion, gross profit was $970.5 million, net income was $236.5 million, and earnings per share were approximately $2.81.

What's Driving the Stock

  • HealthEquity raised its fiscal 2027 outlook following its first-half performance and now expects revenue between $1.411 billion and $1.421 billion, GAAP net income between $242 million and $248 million, and adjusted earnings before interest, taxes, depreciation, and amortization between $628 million and $636 million.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • New HSA accounts generated from sales reached a record level for Q2 fiscal 2027 and grew 24% year over year, while total HSA accounts grew 8% and their assets grew 14%, and client renewals remained on track to exceed 90% for fiscal 2027.
  • The number of monthly active app users reached 1.4 million in July 2026, up 62% year over year, and cumulative downloads exceeded 5 million; the company also intends to integrate HSA and FSA accounts, reimbursements, investing, Marketplace, and education into the next-generation HealthEquity app during the months following the August 27, 2026 call.
  • The number of active Marketplace members exceeded 14 thousand by the end of Q2 fiscal 2027, and the Health Savings Days campaign attracted approximately 500 thousand unique visitors during the week referenced in the August 27, 2026 call. Programs and transactions unrelated to metabolic health came to represent approximately one-third of Marketplace revenue, although the business's contribution to overall results remained immaterial in that quarter.
  • AI-enabled automation reduced service cost per account in Q2 fiscal 2027; it handled 85% of routine chat inquiries and contained 55% of card-related phone contacts. Employee-handled calls declined 25% year over year, and card calls fell 30%, contributing to an increase in gross margin to approximately 74% and adjusted earnings before interest, taxes, depreciation, and amortization margin to 48%.
  • Custodial revenue increased 10% to $175.9 million in Q2 fiscal 2027, with an annualized yield on HSA cash balances of 3.83%. The company raised its expected yield range for fiscal 2027 to between 3.85% and 3.90%, benefiting from repricing and increased participation in enhanced rates.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Q2 fiscal 2027 combines an acceleration in revenue growth to 8%, an 11% increase in adjusted earnings before interest, taxes, depreciation, and amortization, and a two-percentage-point expansion in its margin to 48%, providing numerical evidence of improving operating leverage.
    • +The expanding HSA base provides a recurring revenue driver; accounts reached 10.7 million, new accounts generated from sales grew 24%, and HSA assets increased 14% in Q2 fiscal 2027, with client renewals on track to exceed 90%.
    • +Investing within HSA accounts remains an area with room for expansion, as only approximately 9% of the total HSA base was investing by the end of Q2 fiscal 2027, despite investor count growth of more than 20% and a 28% increase in invested assets. The company launched SimplyInvest with no administrative fees to lower the barrier to entry and increase engagement.
    • +Operating cash flow provided flexibility to support growth and return capital; the company generated $136 million in operating cash flow in Q2 fiscal 2027 and repurchased approximately $108 million of shares, with approximately $948 million remaining under the cumulative $1.6 billion repurchase authorization.

    ▼ Selling Case5 pts

    • −Custodial revenue, which totaled $175.9 million and was the largest component of Q2 fiscal 2027 revenue, depends on yields on HSA cash balances and the repricing of deposit contracts; contracts covering $2.3 billion in cash balances were due to be repriced during fiscal 2027. Despite hedges, management explained that the variable-rate component and uncommitted balances could affect the yield, and that the market indicators used in the assumptions might not accurately predict actual conditions.
    • −HealthEquity operates in a highly competitive market, and the chief financial officer acknowledged during the August 27, 2026 call that there was disclosed year-over-year erosion in service pricing and that competitors were also seeking to reduce their costs. The company may therefore have to pass a larger portion of automation savings to clients instead of retaining them within margins.
    • −Marketplace remains at an early stage, and its revenue was not material to Q2 fiscal 2027 results, despite reaching more than 14 thousand active members and attracting 500 thousand unique visitors during the Health Savings Days campaign. This means that traffic and improved conversion do not yet demonstrate the business's ability to produce a meaningful financial impact at the group level.
    • −Outstanding debt was approximately $931 million, net of issuance costs, at the end of Q2 fiscal 2027, compared with $256 million in cash. Despite generating $136 million in operating cash flow during the quarter, funding investments, repurchasing shares, and reducing revolving facility borrowings require an ongoing capital-allocation trade-off.
    • −Insider transactions showed a strong_sell signal during the three months ending August 25, 2026, with six sales, no recorded purchases, and net selling of $2.2 million. This remains a weak signal on its own because insider sales may be prearranged, and the data did not specify the reasons for these transactions.

    Valuation

    Analyst consensus rates HQY shares as “Buy,” with an average price target of $110 and a narrow target range between $105 and $115. The average target is slightly above the top of the 52-week range of $107.62, while the stock's annual range extends from $72.76 to $107.62; no price-to-earnings multiple is provided in the data for assessing valuation using this measure. The raised fiscal 2027 outlook supports the positive view, but risks related to custodial revenue's interest-rate sensitivity, service pricing erosion, and the debt burden remain important factors when assessing the sustainability of the targets.

    BuyAnalyst target: $110(+14.3%)

    Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.

    FAQ

    What drove HQY's results in Q2 fiscal 2027?

    HealthEquity's revenue grew 8% year over year to $350.7 million in Q2 fiscal 2027. Custodial revenue was $175.9 million, service revenue was $124.4 million, and interchange revenue was $50.4 million. Gross margin also increased to approximately 74%, and adjusted earnings before interest, taxes, depreciation, and amortization margin reached a record 48%.

    What is HealthEquity's fiscal 2027 outlook following its second-quarter results?

    On August 27, 2026, the company raised its fiscal 2027 revenue outlook to a range between $1.411 billion and $1.421 billion. It expects GAAP net income between $242 million and $248 million, or between $2.88 and $2.96 per share. It also expects adjusted earnings before interest, taxes, depreciation, and amortization between $628 million and $636 million, and non-GAAP net income between $392 million and $398 million.

    How is HealthEquity using artificial intelligence to improve profitability?

    In Q2 fiscal 2027, HealthEquity used artificial intelligence in member service, client onboarding, multilingual materials, claims automation, and fraud prevention. Automated tools handled 85% of routine chat inquiries and contained 55% of card-related contacts. Employee-handled calls declined 25% year over year, while card calls fell 30%, contributing to an adjusted earnings before interest, taxes, depreciation, and amortization margin of 48%.

    How large is the opportunity for Marketplace and the new HealthEquity app?

    The number of active Marketplace members exceeded 14 thousand by the end of Q2 fiscal 2027, but its revenue remained immaterial to the company's results. In the campaign referenced during the August 27, 2026 call, Health Savings Days attracted approximately 500 thousand unique visitors and recorded the highest weekly traffic and sales in Marketplace's history. The company plans to integrate HSA, FSA, reimbursements, investing, education, and Marketplace into the next-generation HealthEquity app, building on 1.4 million monthly active users in July 2026 and more than 5 million cumulative downloads.

    Why are HSA accounts and investing within them an important driver for HQY?

    The number of HSA accounts reached a record 10.7 million in Q2 fiscal 2027, with total accounts growing 8% and assets growing 14% year over year. New accounts generated from sales increased 24%, marking the best second quarter and the strongest quarter outside the fourth-quarter open enrollment period. Invested assets within HSA also grew 28%, and the company launched SimplyInvest with no administrative fees, while only approximately 9% of the HSA base was investing by the end of the quarter.

    What are the main risks to monitor for HQY shares?

    Custodial revenue was $175.9 million in Q2 fiscal 2027, so the company's results remain sensitive to yields on cash balances and the repricing of HSA contracts, including $2.3 billion of contracts scheduled to be repriced during fiscal 2027. Management also acknowledged service pricing erosion and intense competition on August 27, 2026, which may limit the company's ability to retain all artificial intelligence savings. In addition, debt was approximately $931 million compared with $256 million in cash at the end of the quarter, while Marketplace remains financially immaterial despite growing engagement.